Start your pain free life today!

Regenexx Hip Stem Cell Therapy

The Catalyst Pain Solutions’ family of hip surgery alternatives are breakthrough, non-surgical stem-cell treatments for people suffering from hip pain due to common injuries, hip arthritis, avascular necrosis, osteonecrosis, hip bursitis or other degenerative problems related to the hip joint. Are you a good candidate for our Regenerative Stem Cell Procedures?
Complete The Form

Regenerative Procedures for Hips

At Catalyst Pain Solutions, our Regenerative stem cell procedures begin when the doctor takes some blood from a vein in your arm. These samples are then sent to the lab, which is part of our medical practice. Your cells are processed and then re-injected into the area in need of repair using imaging guidance (real time fluoroscopy or musculoskeletal ultrasound, using your MRI to plan the injection). They can either be processed the same day (U.S.) or cultured over a two-week span to get more cells (culturing only available through a company that has licensed the procedure for use at a Cayman Islands facility).
For the same day procedure, our trained staff uses our advanced clean room lab to isolate the mesenchymal stem cells sample. These cells are then injected back into the injured area on the same day, with natural growth factors found in your blood platelets. The goal is to deliver much greater numbers of stem cells to the injured area than your body would deliver on its own. For more detail about the procedure, see the Frequently Asked Questions (FAQ’s).
What makes Catalyst Pain Solutions’ Regenerative Stem Cell Procedures different than other same-day stem cell procedures being offered? First, we don’t use a one size fits all centrifuge to prepare cells, we use a sophisticated lab that is part of our medical practice. Second, while some practices add platelet rich plasma to their stem cell concentrate, we use a proprietary “super platelet” mix. The birth of this “super platelet” mix was a series of lab experiments we ran in 2009. By mixing lab prepared PRP (slow release growth factors) and platelet lysate (immediately available growth factors), we were able to get adult stem cells to grow many times more than just PRP or platelet lysate alone.

Hip Conditions Commonly Treated with Stem Cell & Platelet Procedures

The list below represents the most commonly treated hip conditions using Regenerative Stem Cell or Platelet Procedures.

This is not a complete list, so please contact us or complete the Candidate Form if you have questions about whether you or your condition can be treated with these non-surgical procedures. The type of procedure used (stem cell or blood platelet) to treat these conditions is largely dependent upon the severity of the injury or condition.
- Avascular Necrosis
- Osteonecrosis
- Bursitis
- ArthritisTendinopathy
- Labral / labrum tear

2013 Regenerative Hip Patient Outcome Data

Efficacy and Safety of Bone Marrow Concentrate for Osteoarthritis of the Hip; Treatment Registry Results for 196 Patients

Introduction: We investigated the efficacy and safety of autologous bone marrow concentrate (BMC) for the treatment of symptomatic hip osteoarthritis.

Methods: Treatment registry data for 216 hips treated among 196 patients who underwent a BMC procedure for hip osteoarthritis (OA) were analyzed. Data regarding adverse events (AEs), subjective percentage improvement, Oxford Hip Scores (OHS), and numeric pain scale (NPS) scores were assessed and compared to baseline at 1, 3, 6 months, and annually after treatment.

Results: The mean reported subjective percentage improvement across all 216 treated hips was 30.2%. The mean OHS change was 6.4 points improved (p<0.001). The NPS scores from baseline to post treatment decreased from 4.5 to 3.3 (p<0.001). Twelve AEs were reported, none of which were serious or persisting. Patients ≤ 55 years old were substantially more likely to report improvement on the OHS [OR: 11.1 (1.6-77.8)] and also more likely to report greater than 50% improvement on the subjective percentage improvement scale [OR: 2.8 (1.2-6.7)].

Conclusion: The present study of BMC injections for hip OA demonstrated encouraging results for improved outcomes with no significant complications. We found that patients younger than 55 years old were more likely to report improvement on the OHS and subjective percentage improvement scales. Further study with randomized trials is warranted to confirm the reported results.

Hip Patient Outcome Data

This data looks at patient outcomes for same-day stem cell treatments for hip arthritis.
CPS-011017-file-view-banner-sm-hip1 Regenexx Hip Stem Cell Therapy

Start Living Pain Free Today

Fill out the form below to get started.
  • This field is for validation purposes and should be left unchanged.

Common Pain Areas

What pain are you experiencing?
Compare Costs playphoneenvelope